ROCKWELL MEDICAL ANNOUNCES UPDATED DSMB RESULTS.(Financial report)

Biotech Business, December, 2008

Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), Wixom, Mich., a specialty pharma company focused on drug and device development in the renal market, has reported that the independent Data Safety Monitoring Board (DSMB) providing oversight for the SFP Phase II-b iron maintenance therapy dose-range study reviewed the cumulative safety data from the ongoing clinical study and informed the company that it has identified no safety concerns. The DSMB also recommended the continuation of the study with no modifications.

"We are ...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement